The emergence of antibiotic-resistant Helicobacter pylori strains impacts the efficacy of eradication therapy and promotes the development of alternative treatment strategies. Apocynin inhibits neutrophil NADPH oxidase and hence may decrease reactive oxygen species-mediated tissue damage in H. pylori-infected stomach tissue. Apocynin was tested in vitro for its cytotoxic and direct antibacterial effects. The therapeutic efficacy of orally administered apocynin (100 mg/kg/day through drinking water or 200 mg/kg/day through combined administration of drinking water and slow-release formulation) was assessed at 9 weeks after infection in the Mongolian gerbil model. Bacterial burdens were quantified by viable plate count and quantitative PCR. Histopathological evaluation of antrum and pylorus provided insight into mucosal inflammation and injury. Apocynin showed no cytotoxic or direct antibacterial effects in vitro or in vivo. Nine weeks of apocynin treatment at 200 mg/kg/day reduced active H. pylori gastritis as neutrophil infiltration in the mucous neck region and pit abscess formation decreased significantly. In our gerbil model, prolonged high-dose apocynin treatment significantly improved H. pylori-induced pit abscess formation without indications of drug toxicity and thus further investigation of the dosage regimen and formulation and the long-term impact on neoplastic development should be carried out. European Journal of Cancer Prevention 26:10-16 Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
Introduction
Helicobacter pylori is a gram-negative bacterium that resides in the gastric mucosa of about half the world's population (Dunn et al., 1997) . Despite the acute inflammatory reaction upon colonization, the immune system cannot clear H. pylori infection as it evades and modulates the primary immunological responders (Muller et al., 2011; Rubin and Trent, 2013) . Although neutrophils and macrophages have the capacity to phagocytize and kill most bacterial invaders, H. pylori deploys an arsenal of mediators, such as superoxide dismutase (SodB), catalase (KatA), and alkyl hydroperoxide reductase (AhpC), to protect itself against reactive oxygen species (ROS) and antibacterial proteins in the phagosome (5,6). In addition, H. pylori directs NADPH oxidase (NOX) targeting toward the cell membrane, which results in the massive release of superoxide radicals (O 2 • − ) into the extracellular space. As such, persistently infected stomach tissue is continuously exposed to cytotoxic bacterial virulence factors and ROS (Allen and McCaffrey, 2007) . Depending on multiple bacterial, immunological, and environmental factors, H. pylori infection leads to a variety of clinical outcomes, ranging from asymptomatic chronic gastritis over gastric ulcers to gastric carcinoma or lymphoma (Allen and McCaffrey, 2007; Hardbower et al., 2013) . As 10-20% of H. pyloriinfected individuals develop significant morbidity, current treatment guidelines aim to clear the infection immediately after diagnosis using a combination of two antibiotics and a proton pump inhibitor (Malfertheiner et al., 2012) . However, emerging antibiotic resistance threatens this treatment paradigm and highlights the need for alternative therapeutic options (Ayala et al., 2014) .
Apocynin or acetovanillone is a nontoxic, natural organic compound that has been used extensively in oriental medicine for a variety of conditions (Xu et al., 2014) . Besides the direct inhibition of neutrophil NADPH oxidase, apocynin prevents the activation of NF-κB, which is an important mediator of gastric inflammation (Barnes and Larin, 1997; Lafeber et al., 1999) . Apocynin has already been preclinically investigated to tackle inflammatory disorders, such as Parkinson's and Alzheimer's disease, and proved to inhibit airway inflammation in a clinical trial with asthma patients (Lull et al., 2011; Ghosh et al., 2012; Stefanska et al., 2012) . This study assessed the anti-inflammatory activity of apocynin in the Mongolian gerbil model for H. pylori-induced gastritis.
Methods

Apocynin
Apocynin was purchased from Sigma-Aldrich (Diegem, Belgium; ≥ 98% purity). To obtain slow-release (SR) floating microspheres, apocynin was added to molten stearic acid (Mosselman, Ghlin, Belgium), homogenized, and cooled (Umamaheshwari et al., 2003) . Thereafter, the solidified matrix was ground and the fraction of particles smaller than 300 μm was isolated. The content of apocynin in the stearic acid particles was 30%.
Helicobacter pylori culture
The highly virulent Sydney strain 1 (SS1) (kindly provided by Sara Lindén, Gothenburg University, Sweden), which is CagA and VacA s2m2 positive, was grown for 48 h on tryptic soy agar (Lab M Limited, Lancashire, UK) plates supplemented with 5% sheep blood (Oxoid, Cambridge, UK). The plates were incubated at 37°C under microaerophilic conditions (5% O 2 , 10% CO 2 , 85% N 2 ), generated by a Whitley H35 Hypoxystation (Don Whitley, West Yorkshire, UK) and transferred to liquid tryptic soy broth (TSB) (Lab M Limited, Lancashire, UK) containing 10% inactivated fetal calf serum (Invitrogen, Ghent, Belgium) 24 h before inoculation of the gerbils.
Antibacterial effect of apocynin on H. pylori
The minimal inhibitory concentration (MIC) of apocynin was evaluated using agar dilution according to the Clinical Laboratory and Standards Institute guidelines (Clinical and Laboratory Standards Institute, 2006) . The test concentrations ranged from 0.5 to 256 μg/ml.
Cytotoxicity of apocynin on MRC-5 cells
Assays were performed in 96-well microtiter plates, each well containing 1 × 10 4 MRC-5 cells/well. After 72 h of incubation with the test compound (0.244 nmol/l to 64 μmol/l), cell viability was assessed fluorimetrically after the addition of resazurin (Sigma-Aldrich) (λ ex = 550 nm, λ em = 590 nm). The results were expressed as % reduction in cell growth/viability compared with untreated control wells.
Animals
Female Mongolian gerbils (5 weeks old, 45-50 g; Charles River, Leiden, the Netherlands) were housed in groups of two at 20°C and 50% humidity with a light/dark cycle of 12/12 h and food and sterilized drinking water (DW) ad libitum (Carfil Quality, Turnhout, Belgium). The body weight and behavior of the animals were recorded to detect drug toxicity. The ethical committee of the University of Antwerp approved the design and procedures of the animal experiment (File 2010-30).
In-vivo experimental design Table 1 shows the control and treatment groups to which 35 gerbils were assigned randomly. Groups 1 and 2 served as uninfected controls and were administered sterilized tap water without or with apocynin, respectively (Table 1) . At the start of the experiment (day 0), groups 3, 4, 5, and 6 were infected with 0.1 ml of TSB containing 1 × 10 9 CFU H. pylori/ml by an oral gavage at two time points with an interval of 1 h. This procedure was repeated after 48 h. The gerbils were fasted from 4 h before infection until 4 h after gavage. The uninfected controls (1 and 2) were only administered TSB.
Immediately after H. pylori infection, the gerbils of the treated groups (4 and 6) were exposed to apocynin dissolved in their DW. The total daily water intake of Mongolian gerbils was estimated to be about 8-13% of their body weight (McManus, 1972) . For gerbils of about 60 g, the daily dose of 100 mg apocynin/kg body weight could be attained by dissolving 1.538 g apocynin in 2 l sterilized and preheated (60°C) tap water (0.769 g/l). This volume was divided over 10 drinking bottles. The DW was refreshed three times per week and the weight of the bottles was monitored to estimate the amount of water consumed. Group 6 received a supplementary dose of an apocynin/stearic acid (SA) SR formulation (100 mg apocynin/kg suspended in 0.1% NaCMC once daily for 5 days per week) to maximize exposure to the compound. Group 5 served as an SA gavage control and received only SA in 0.1% NaCMC with the same dosing schedule.
Nine weeks after infection, the gerbils were killed by a CO 2 overdose for aseptic removal of the stomach. The tissue was weighed, opened along the greater curvature to obtain two equal parts, and washed with PBS. One half was divided longitudinally and subjected to (a) DNA extraction for real-time quantitative PCR (qPCR), and (b) homogenization to cultivate H. pylori; the other half was also divided into two sections for histopathological examination.
DNA extraction from stomach tissue
One quarter of the stomach tissue was weighed, cut into small pieces using a scalpel blade, and collected in an Eppendorf tube. DNA extraction was performed using the QIAamp DNA Mini kit (QIAgen, Venlo, the Netherlands) according to the manufacturer's instructions.
qPCR quantification of H. pylori Sybr Green-based qPCRs for the H. pylori 16s rRNA gene were performed as described by Yamazaki et al. (2005) in a StepOnePlus Real-Time PCR system (Applied Biosystems, Foster City, California, USA). Each 20 μl reaction mixture contained 10 μl of Power SYBR Green PCR Master Mix (Applied Biosystems), 4 pmol of each primer, 5 μl of the DNA sample, and PCR water (Sigma-Aldrich). A 10-fold serial dilution series of H. pylori DNA (11.99-11.99 × 10 5 fg/μl) was used to construct the standard curve for quantification of the bacterial burden. Three technical replicates were analyzed for each sample. Thermal cycling conditions involved an initial denaturation step of 95°C for 10 min and 40 cycles at 95°C for 15 s (denaturation) and 60°C for 1 min (annealing and elongation).
Helicobacter pylori cultivation from stomach tissue
One quarter of the stomach tissue was weighed, collected in 1 ml TSB, and homogenized (TissueRuptor; QIAgen). The homogenate was immediately placed under microaerophilic conditions (5% O 2 , 10% CO 2 , 85% N 2 ) in a Whitley H35 Hypoxystation and serially diluted for viable plate counting (VPC). Dilutions were spread onto tryptic soy agar plates, supplemented with 5% sheep blood, vancomycin (10 μg/ml), trimethoprim (5 μg/ml), amphotericin B (5 μg/ml), and cefsulodin (10 μg/ml) (all purchased from Sigma-Aldrich), and incubated at 37°C under microaerophilic conditions for 5-10 days.
Histopathological evaluation
Tissue sections were stretched on Sylgard 184 (SigmaAldrich) in a Petri dish and fixed for 1 h in 4% paraformaldehyde (Sigma-Aldrich) in PBS at room temperature. The tissue was rinsed three times for 10 min with PBS and stored in PBS + 0.01% NaN 3 at 4°C. After fixation, the tissue was processed in a Citadel 2000 (Thermo Fisher Scientific, Aalst, Belgium) and embedded in paraffin. Tissue sections of 5 μm were cut and stained with H&E or an H. pylori-specific antibody. An experienced histopathologist scored an entire antral or pyloric section of each animal in a blinded manner for three different parameters (Table 2) .
Results
Apocynin does not inhibit in-vitro growth of H. pylori
After 5 days of in-vitro culture, all H. pylori colonies showed the same size and morphology on the agar plates containing different concentrations of apocynin. As apocynin had no inhibitory effect on the growth of H. pylori, no MIC value could be determined (MIC > 256 μg/ml).
Apocynin does not affect cell viability up to 64 μmol/l Fluorimetric assessment of MRC-5 cells after resazurin staining indicated that the cell viability and growth of apocynin-treated cells were comparable with that of the untreated controls, confirming the noncytotoxic nature of the compound (IC 50 > 64 μmol/l).
Apocynin treatment does not affect H. pylori burden in the gerbil stomach
The load of H. pylori per gram stomach tissue was determined by qPCR, detecting all H. pylori DNA in the stomach, and by VPC, quantifying all viable H. pylori. The uninfected control groups (1 and 2, data not shown) had no H. pylori in their stomach, whereas all infected groups (3-6) showed similar bacterial burdens for both qPCR and VPC (Kruskal-Wallis, n = 4 or 6, P > 0.05) (Fig. 1) .
Oral exposure to apocynin by DW failed to influence H. pylori-induced inflammation H&E-stained tissue sections were histologically assessed. For each animal, slides containing antrum and pylorus were scored in a blinded manner for different parameters ( Table 2 ). The stomach tissue of the animals in groups 1 or 2 showed normal histology without signs of inflammation. Immunohistochemical staining confirmed the presence of the bacterium in all infected gerbils, whereas no H. pylori bacteria were found in the uninfected groups. Figure 2 shows that exposure of infected gerbils to DW with a concentration of 0.769 g/l apocynin did not influence the inflammatory progression of H. pylori infection. Compared with the infected control group (3), neutrophil influx or abscess formation in the antrum and pylorus region remained unaltered upon apocynin exposure (group 4, χ 2 , n = 6, P > 0.05). In addition, the same levels of lymphocytic infiltration were observed (data not shown, χ 2 , n = 6, P > 0.05). Oral treatment with SR apocynin significantly decreased pit abscess formation Figure 3 shows that oral treatment with SR apocynin ameliorated H. pylori-induced gastritis as less pit abscess formation (Fig. 4) was observed in the treated group (6) compared with the SA gavage controls (group 5, χ 2 , n = 4 and 7, P = 0.044). The influx of lymphocytes was comparable in both groups (data not shown, χ 2 , n = 4 and 7, P > 0.05).
Discussion
This study evaluated the inhibitory effect of apocynin on H. pylori-induced inflammation. In the immune response to H. pylori colonization of the human stomach, neutrophils provide the first line of defense (Guang et al., 2012) . The production of ROS, proteolytic enzymes, and antimicrobial peptides forms the basis of the neutrophil's protective capacity, but these molecules do not selectively destroy invading microbes (Handa et al., 2010) . The combination of neutrophil ROS and bacterial virulence factors causes collateral damage to the gastric epithelium (Cadamuro et al., 2014) . As apocynin directly inhibits O 2
• − -producing NADPH oxidase of neutrophils and macrophages, this natural compound could prevent cytotoxic ROS formation and limit subsequent gastric tissue injury (Stefanska and Pawliczak, 2008) .
Successful in-vivo studies using anti-inflammatory molecules, such as capsaicin and irsogladine, to tackle H. pylori-induced disease promote the concept of nonantimicrobial therapeutic approaches, that is, the modulation of the pathogenesis without bacterial eradication (Akagi et al., 2013; Mozsik, 2014) . The promising reports of apocynin treatment of several inflammatory disorders led us to explore its effect on gastric injury because of H. pylori infection. In a mouse model of zymosaninduced acute arthritis, oral administration of apocynin improved proteoglycan synthesis significantly in the (right) . No statistically significant differences were found between the untreated and treated groups (Kruskal-Wallis, n = 4-6, P > 0.05). APO, apocynin; C, control; DW, drinking water; SA, stearic acid; SR, slow release; T, treatment. , n = 6, P > 0.05). APO, apocynin; C, control; DW, drinking water; T, treatment. Histopathological scoring of neutrophil influx in stomach tissue of gerbils treated daily with a slow-release formulation of apocynin and apocyninsupplemented drinking water versus vehicle controls (χ 2 , n = 4-7, P = 0.044, indicated by *). APO, apocynin; C, control; SA, stearic acid; SR, slow release; T, treatment.
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knee-joint (Hougee et al., 2006) . Apocynin treatment in a marmoset model of Parkinson's disease mitigated the disease progression, limiting the parkinsonian signs and motor-function deterioration (Philippens et al., 2013) . Moreover, a clinical trial using nebulized apocynin reported a reduction of ROS concentrations in the exhaled breath condensate of asthma patients (Stefanska et al., 2012) .
The existing data indicate a clear anti-inflammatory effect in vivo, which may be related to the direct inhibitory effects on the neutrophil's respiratory burst or the prevention of NF-κB activation. In a previous study, our research group (Horemans et al., 2014 -in preparation) used electron paramagnetic resonance measurements to show that apocynin significantly inhibits the respiratory burst of neutrophils stimulated with opsonized zymosan particles (OPZ). As OPZ stimulates neutrophils through cell membrane receptor binding like microorganisms do, we considered OPZ a proxy for bacterial activation of neutrophils. As such, our study suggests a therapeutic role for apocynin in infectious diseases in which neutrophils contribute toward the pathogenesis rather than providing protection to the host. This is the case for H. pylori-induced gastric inflammation, but also for disease caused by Mycobacterium tuberculosis (Eruslanov et al., 2005) . Treatment with apocynin could prevent the generation of extracellular release of ROS and an important part of the associated tissue damage (Kennett et al., 2011) .
This study evaluated the therapeutic efficacy of apocynin in the gerbil model for H. pylori infection because its inflammatory course is comparable with that in humans.
As apocynin is expected to influence neutrophil activity, mouse models, which are characterized by mononuclear cell infiltration instead of neutrophil influx, were considered less suitable (Zhang and Moss, 2012) . Infection of the gerbil stomach with H. pylori SS1 leads to the recruitment of inflammatory cells from 3 weeks after infection and results in histopathologically well-described gastric disease over a period from 4 to 64 weeks after infection (Elfvin et al., 2005; Wiedemann et al., 2009; Chandan et al., 2013) . In the antrum, severe active gastritis can be observed at 8 weeks after infection, whereas the corporal inflammation increases gradually over time. Early precancerous conditions, such as atrophy, metaplasia, and dysplasia, start to develop from 8 weeks after infection (Wiedemann et al., 2009) . The variability of the disease outcomes can most likely be explained by the outbred characteristic of the rodents and their genetic heterogeneity. H. pylori SS1 is a firm colonizer of the gerbil stomach, which is reflected by our 100% infection rate, also ensuring the establishment of a reproducible animal model. A drawback of the gerbil model is the lack of transgenic or specific gene knockout strains and the limited commercial availability of immunological reagents.
As this study was the first to explore the effect of apocynin on the clinical outcome of H. pylori-infection, the dosing regimen was designed to obtain the highest possible concentration and exposure time in the stomach. The absence of cytotoxicity and side effects in earlier studies and in our own in-vitro assessment enabled us to use high doses of apocynin to maximize the pharmacological effect. Approximately 100 mg/kg apocynin was administrated through the DW and 200 mg/kg when the DW was supplemented with the daily administration of the SR formulation of apocynin (de Almeida et al., 2011; Pedroso et al., 2013) . In addition, apocynin administration was started at the time of infection and continued until 9 weeks after infection, when histopathological signs of active gastritis generally become apparent in untreated animals. As a water-soluble compound, apocynin allowed oral administration through DW. This mode of administration offers a comfortable way of treating animals for a longer period of time and directs the compound immediately to the desired site of action. To further maximize exposure and to compensate for the limited uptake during the night because of the circadian drinking pattern, one treatment group (6) received an SR formulation of apocynin and SA (Rodriguez et al., 1999) .
Nine weeks after infection and initiation of treatment, the stomachs were excised for in-depth morphological and microbiological evaluation. The qPCR and VPC data on bacterial burden were in line with our in-vitro finding that apocynin treatment exerts no effect on H. pylori viability, growth, or attachment (Fig. 1) . Light microscopic image of a pit abscess (left upper corner) and lymphocytic infiltration at the base of the mucosa in an untreated gerbil (H&E stain, × 40).
Histopathological analysis was based on tissue sections containing the gastric regions antrum and pylorus because they consistently show a high infectious load and severe gastritis at 9 weeks after infection in control animals. Immunohistochemistry confirmed the presence of H. pylori in all infected gerbil stomachs. Untreated (group 1) and treated (group 2) uninfected animals showed no H. pylori and normal gastric histology, indicating that apocynin has no direct effect on the stomach tissue. For the infected animals, the administration of apocynin through DW (group 4) did not affect neutrophil influx or abscess formation. However, the combined administration of apocynin in DW and SR formulation (group 6) significantly decreased pit abscess formation in the mucous neck region compared with the SA control group (group 5). This interesting finding suggests that apocynin has the capacity to positively modulate the inflammatory process and may thus reduce H. pylori-induced tissue damage.
Given the small study size and the importance of the dosage strategy, additional experiments in the gerbil model are required to gain full insight into the therapeutic potential of apocynin. First, assessment of its effect on neoplastic development at 32-64 weeks after infection could convincingly show its applicability in chronic gastric disease. Equally important is the optimization of the daily dosage and formulation approach. As we hypothesized that apocynin should influence the activity of neutrophils that accumulate in the stomach upon H. pylori colonization, we aimed to maximize the exposure of these immune cells. In this exploratory study, apocynin in DW and as an SR formulation were combined to compensate for (a) the dilution effect of the stomach fluid, (b) the limited retention time because of gastric emptying, and (c) the challenging diffusion toward neutrophils that are hidden in the stomach mucosa (Harsha, 2012) . Possibly, higher dosages are even more effective in inhibiting the ROS production, but caution is warranted as Tang et al. (2008) highlighted the delicate balance between the proinflammatory and antiinflammatory effects of apocynin treatment. The narrow therapeutic window that was reported for the treatment of experimental stroke is supported by the pro-oxidant activity of high doses in vitro (Castor et al., 2010; Connell and Saleh, 2012) .
The optimal dosage regimen for efficacy in the stomach should be based on apocynin concentrations in the gastric mucosa (Gustavson et al., 1995) . A recent pharmacokinetic study on plasma levels showed a short half-life (t 1/2 = 6 min) and very limited oral bioavailability of apocynin in rats (Wang et al., 2013) . Although these compound characteristics complicate systemic treatment with apocynin, the short half-life supports our localized and continuous treatment strategy. The SR formulation allowed prolonged exposure of the mucosal immune cells without accumulation of the compound in the circulation. Modification of the drug delivery mode, for example, using mucoadhesive or mucopenetrating systems, could further enhance the gastric retention time (Conway, 2005; Arora et al., 2011; Zhao et al., 2014) .
In conclusion, this is the first study to explore the therapeutic potential of apocynin on H. pylori-induced inflammation. In our gerbil model, prolonged, high-dose apocynin treatment significantly reduced pit abscess formation without indications of drug toxicity. Our promising results provide incentive to further investigate the dosage regimen and formulation and study the long-term impact on neoplastic development.
